nature上有關(guān)茶的優(yōu)秀論文

1、EGCG regulates cell growth, cell cycle and phosphorylated nuclear factor-Kb in human dermal fibroblastsEGCG對(duì)人體皮膚成纖維細(xì)胞的生長(zhǎng)、細(xì)胞周期和磷酸化的核因子的影響Aim: to investigate the effects of EGCG, the main polyphenol in green tea, on cell growth, cell cycle and phosphorylated nuclearfactor-kB expression in neonatal hum

2、an dermal fibroblast.Methods: The proliferation(增殖) and cell-cycle of nHDFs were determined using WST-8 cell growth assay(測(cè)定) and flow cytometry(流體細(xì)胞儀), respectively(分別地). The apoptosis(細(xì)胞凋亡) was examined using DNA ladder and Annexin V-FITC assays. The expression levels of pNF-B and cell cycle-relat

3、ed genes and proteins in nHDFs were measured using cDNA microarray(芯片) analyses and Western blot. The cellular uptake(攝取) of EGCG was examined using fluorescence (FITC)-labeled EGCG (FITC-EGCG) in combination with confocal microscopy(多聚焦顯微鏡).Results: The effect of EGCG on the growth of nHDFs depende

4、d on the concentration(濃度) tested. At a low concentration (200 mol/L), EGCG resulted in a slight decrease in the proportion(比例) of cells in the S and G2/M phases of cell cycle with a concomitant(附隨的) increase in the proportion of cells in G0/G1 phase. At the higher doses(劑量) (400 and 800 mol/L), apo

5、ptosis(細(xì)胞凋亡) was induced. The regulation(調(diào)節(jié)) of EGCG on the expression of pNF-B was also concentration-dependent(濃度依賴性), whereas(但是) it did not affect the unphosphorylated(磷酸化) NF-B expression. cDNA microarray(芯片) analysis showed that cell cycle-related genes were down-regulated by EGCG (200 mol/L).

6、 The expression of cyclins(細(xì)胞周期蛋白) A/B and cyclin-dependent kinase(致活酶) 1 was reversibly(可逆地) regulated by EGCG (200 mol/L). FITC-EGCG was found to be internalized(內(nèi)化) into the cytoplasm(細(xì)胞質(zhì)) and translocated(易位) into the nucleus of nHDFs.Conclusion: EGCG, through uptake(攝取) into cytoplasm(細(xì)胞質(zhì)), rev

7、ersibly(可逆地) regulated the cell growth and expression of cell cycle-related proteins and genes in normal fibroblasts.IntroductionFood bioactives(生物活性物質(zhì)) with strong antioxidant(抗氧化劑) properties(性能) have been shown to be contained in green tea, grapes, and turmeric and have shown cancer chemopreventi

8、ve(化學(xué)預(yù)防) and chemotherapeutic(化學(xué)療法) effects in many animal tumor(腫瘤) bioassays(生物測(cè)定), cell culture systems, and epidemiological(流行病學(xué)的) studies13. These biological activities of green tea polyphenols(多酚) are believed to be mostly mediated(介導(dǎo)) by ()epigallocatechin-3-gallate (EGCG), the predominant(主要

9、的) catechin(兒茶素) present therein4. Some previous reports have shown that treatment with EGCG or its derivatives(提取物) results in G0/G1 phase cell cycle arrest(抑制) and apoptosis(細(xì)胞凋亡) of several types of cancer cells, but not of normal cells57. However, the mechanism(機(jī)理) of this differential response

10、to EGCG in cancer cells vs normal cells has not been fully elucidated(闡明). Many previous studies have reported the incorporation(摻入) of EGCG into the cytosol(細(xì)胞質(zhì))l and/or even the nucleus of cancer cells. The EGCG tissue distribution(分布)and metabolism(代謝) in animals has also been assessed using radi

11、oisotope-labeled EGCG, eg, 3 HEGCG811. This cellular(細(xì)胞) incorporation of EGCG is considered involved in the mechanism(機(jī)理) of the anti-cancer activity of EGCG because catechins(兒茶素) exert(發(fā)揮) proapoptotic(凋亡的) and antiproliferative(抗增殖的) activities on cancer cells. Dietary(膳食) agents that can suppre

12、ss(抑制) the cancer cells via apoptosis(細(xì)胞凋亡) (a programmed cell death) but do not affect normal cells may have a therapeutic(治療) advantage for the elimination(消除) of cancer cells. At present, only a few agents are known to possess the potential for selective/preferential elimination of cancer cells w

13、ithout affecting the normal cells6, 7, 12, 13. EGCG has been shown to have suppressive effects on various cancer cells by inducing cell cycle arrest(阻滯) and inhibiting(抑制) proliferation(增殖)14, 15, whereas less attention has been paid to its cytoprotective(細(xì)胞保護(hù)) effects on normal cells. Our previous

14、reports have demonstrated(證明) that EGCG induces cellular hibernation(休眠) with high cell survival rates through inhibiting apoptosis by scavenging(清除) free radicals(自由基) harmful to the cells and protecting the fragile cell membrane(細(xì)胞膜) by simply adhering(附著) to and reinforcing(加強(qiáng)) it1618.In the pres

15、ent study, we investigated (i) the regulatory effects of low- and high-dose(劑量) treatments of EGCG on the cellular responses and expression of phosphorylated(磷酸化的) nuclear factor-B/p65 (pNF-B/p65) in neonatal(新生兒的) human dermal(皮膚的) fibroblasts (nHDFs), (ii) the reversible(可逆的) effects of EGCG on th

16、e expression of cell cycle-related genes and proteins, and (iii) the involvement of the cellular uptake(攝入)pattern of EGCG as a mechanism(機(jī)制) for these dose-differential responses to EGCG in nHDFs. Our data imply that the proliferation(增殖), cell cycle progression(進(jìn)程), apoptosis(細(xì)胞凋亡) and pNF-B/p65 e

17、xpression of nHDFs are dose-differentially regulated in response to EGCG (200- 800 µmol/L). Cell cycle-related genes and proteins, such as cyclin A (CCNA), CCNB, cyclin-dependent(周期素依賴性蛋白) kinase(激酶) 1 (CDK1) and CDK inhibitor(抑制物) A1 (CDKN1A or p21), were reversibly(可逆地) regulated when the cel

18、ls were subjected to(受的支配) EGCG exposure(曝光) and removal(移除). EGCG conjugated(共軛) with fluorescein(熒光素) isothiocyanate(異硫氰酸酯) (FITC) was found to be incorporated(結(jié)合) into the cytoplasm(細(xì)胞質(zhì)) of nHDFs with further nuclear translocation(易位). The dose-differential regulatory activity of EGCG may be expl

19、oited(利用) to craft(制作) strategies(策略) for the cytoprotection(細(xì)胞保護(hù)作用) of normal cells and cancer chemoprevention(化療) by EGCG.Materials and methods Cell cultures Neonatal human dermal fibroblasts (nHDFs) were kindly provided by Dr Dong Kyun RAH (Department of Plastic and Reconstructive Surgery, Yonsei

20、 University College of Medicine, Seoul, Korea). The cells were routinely maintained in Dulbecco's modified Eagles medium (D6429, Sigma-Aldrich Co, St Louis, MO, USA) supplemented with 10% fetal bovine serum (Sigma-Aldrich Co) and a 1% antibiotic antimycotic solution (including 10000 units penici

21、llin, 10 mg streptomycin and 25 µg amphotericin B per mL, Sigma-Aldrich Co) at 37 °C in a humidified atmosphere of 5% CO2 in air as previously described19. Studies were performed with nHDFs within 10 passages.EGCG treatment EGCG (Teavigo), a major polyphenolic constituent of green tea, was

22、 purchased from DSM Nutritional Products Ltd (Basel, Switzerland), and its purity exceeded 98%. To examine the dose-based differential effects of EGCG on growth, cell cycle progression, apoptosis and pNF-B/p65 expression of nHDFs, the cells were seeded into well plates and incubated in the presence

23、of increasing concentrations (100800 µmol/L) of EGCG in complete medium for 24 h. Upon determining the effects of EGCG on the expression of cell cycle-related genes or proteins, cultured cells were treated with 200 µmol/L EGCG in complete medium for 24 h. After EGCG treatment, EGCG was rem

24、oved from the culture medium and the cells were further incubated for 24 to 72 h.Cell growth assay The number of viable cells was quantified indirectly using a highly water soluble tetrazolium salt WST-8, 2-(2-methoxy- 4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2Htetrazolium, monosodium

25、salt (Dojindo Lab, Kumamoto, Japan) that is reduced to a formazan dye by mitochondrial dehydrogenases. Cell growth was found to be directly proportional to the metabolic reaction products obtained in the WST-8 assay. Briefly, WST-8 assays were conducted as follows. nHDFs cultures treated with increa

26、sing concentrations of EGCG were incubated with WST-8 for the last 4 h of the culture period (24 h) at 37 °C in the dark. To avoid a direct reaction between the antioxidant EGCG and the WST-8 to be reduced, the cell cultures were thoroughly washed with phosphate-buffered saline (PBS, pH 7.2) an

27、d refreshed with a fresh medium containing WST-8. Parallel sets of wells containing freshly cultured, non-treated nHDFs were regarded as the controls. Absorbance was determined at 450 nm using an ELISA reader (SpectraMax© 340, Molecular Device Co, Sunnyvale, CA, USA). At the end of incubation,

28、the cellular morphologies were observed under an Olympus IX70 inverted microscope (Olympus Optical Co, Osaka, Japan).Cell cycle analysis For cell cycle analysis, cultured nHDFs, following treatment with increasing concentrations of EGCG for 24 h, were collected and washed with cold PBS (pH 7.2). The

29、 cells were resuspended in 95% cold methanol for 1 h at 4 °C and then centrifuged at 120×g for 5 min. The resultant pellet was washed twice with cold PBS, suspended in PBS and incubated with RNase (20 Units/mL, final concentration, Sigma-Aldrich Co) at 37 °C for 30 min. Afterward, the

30、 cells were chilled on ice for 10 min and stained with 100 µg/mL propidium iodide (PI, Sigma-Aldrich Co) for 1 h. At least 10 000 cells were counted by a flow cytometer (FACSCalibur, BD Biosciences, San Jose, CA, USA), and the data obtained were analyzed using ModFit LT for Mac version 3.0 soft

31、ware (Verity Software House, Topsham, ME, USA).Apoptosis analysis After treatment of nHDFs with increasing concentrations of EGCG for 24 h, the cellular DNA was isolated and resolved over a 1.5% agarose gel to assess DNA ladder formation (fragmentation) using a standard procedure. Briefly, following

32、 EGCG treatment, the cells were washed twice with PBS (pH 7.2) and incubated with 1.0 mL of cytoplasm extraction buffer (10 mmol/L Tris, pH 7.5, 150 mmol/L NaCl, 5 mmol/L MgCl2, and 0.5% Triton X-100) on ice for 15 min. The cells were centrifuged (14 000×g) at 4 °C and then incubated with

33、1.0 mL of DNA lysis buffer (10 mmol/L Tris, pH 7.5, 400 mmol/L NaCl, 1 mmol/L EDTA, and 1% Triton X-100) for 20 min on ice. The lysate was cleared by centrifugation (14000×g) at 4 °C, and the supernatant was incubated overnight with RNase (0.2 mg/mL) at room temperature and then with Prote

34、inase K (0.1 mg/mL, Sigma-Aldrich Co) for 2 h at 37 °C. DNA was extracted using phenol:chloroform (1:1) and precipitated with 95% ethanol. The DNA precipitate was centrifuged at 14 000×g (4 °C) for 15 min, and the pellet was air-dried and dissolved in 20 mL of TE buffer (10 mmol/L Tri

35、sHCl, pH 8.0, and 1 mmol/L EDTA). The total amount of DNA obtained was resolved over a 1.5% agarose gel containing 0.3 mg/mL ethidium bromide in Trisborate-EDTA buffer. The bands were visualized under a UV transilluminator followed by Polaroid photography. Apoptosis of nHDFs treated with EGCG for 24

36、 h was also determined by the TACS Annexin V-FITC assay (R&D Systems Inc, McKinley Place, MN, USA). Phosphatidylserines exposed on the membrane surface of apoptotic cells were stained with Annexin V-FITC according to the manufacturers instructions. The late apoptotic (or necrotic) cells were sta

37、ined with PI. Parallel sets of wells containing non-treated nHDFs were regarded as the (+) controls. The results were acquired and analyzed with CellQuest© software (BD Biosciences). The population of apoptotic cells was characterized by its high mean fluorescence of Annexin V-FITC in a flow cy

38、tometric histogram.Western blottingAfter treatment with increasing concentrations of EGCG for 24 h, nHDFs were washed twice with cold PBS (10 mmol/L, pH 7.4), and ice-cold RIPA lysis buffer (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA) was added to the cells. After 5 min, the cells were scrape

39、d, and the lysate was centrifuged at 14 000×g for 20 min at 4 °C. Proteins were extracted from the total lysate, and the protein concentration was determined by a BCATM protein assay using the manufacturers protocol (Pierce, Rockford, IL, USA). For immunoblot analysis, 3540 µg of prot

40、ein was run on a 4/20 polyacrylamide-SDS gel (Daiichi Pure Chemicals Co, Ltd, Tokyo, Japan) for 1 h at 30 mA and blotted to a PVDF membrane for 50 min at 35 mA. The membrane was blocked in a blocking buffer (Nacalai Tesque Inc, Kyoto, Japan) for 1 h at room temperature and incubated with rabbit anti

41、-human NF-B/p65 and pNF-B/p65 (Ser 536) polyclonal antibodies (Cell Signaling Technology Inc, Danvers, MA, USA) and, as the reference, mouse anti-human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) monoclonal antibody (International Inc, Temecula, CA, USA). The membrane was treated with either an

42、 anti-mouse IgG (Amersham Biosciences, Buckinghamshire, UK) or an anti-rabbit IgG secondary antibody (Santa Cruz Biotechnology Inc), horseradish peroxidase-conjugated. Protein expression was detected by a Chemilumi-one chemiluminescent kit (Nacalai Tesque Inc) and X-ray film (Fujifilm, Tokyo, Japan)

43、. In the cases of immunoblot analysis for cell cycle-related proteins, such as CCNA, CCNB1, CDK1, and CDKN1A, nHDFs were treated with 200 µmol/L EGCG for 24 h; the EGCG was then removed for further incubation for up to 72 h. Afterward, each protein was extracted from the cell lysate and blotted

44、 to the membrane. The membrane was blocked and incubated with primary antibodies, including either mouse anti-human CCNA, CCNB1, and CDK1 monoclonal antibodies (BD Biosciences) or rabbit anti-human CDKN1A monoclonal antibody (Cell Signaling Technology Inc), followed by incubation with horseradish pe

45、roxidase-conjugated secondary antibodies. Protein expression was detected as described above.Microarray analysisThe effect of EGCG on gene expression of nHDFs was investigated using a Platinum Human Cancer 3.0K oligo microarray (GenoCheck, Ansan, Gyunggi-do, Korea). This microarray consisted of 3096

46、 oligonucleotide spots including Operon (Operon, Huntsville, AL, USA), human oligo subsets, housekeeping genes and Arabidopsis DNA as controls. All oligonucleotide probes were designed from the UniGene Database Build Hs 184 and the Human Reference Sequence Database, both developed and maintained at

47、the National Center for Biotechnology Information. The probes were resuspended in spotting solution (GenoCheck) at a final concentration of 50 pmol/L and spotted onto CMT-GAPS II silane slide glass (Corning, NY, USA) with a PixSys 5500 arrayer (Cartesian Technologies, Irvine, CA, USA) using 6 stealt

48、h micro spotting pins. The printed slides were processed according to the CMT-GAPS II slide protocol.Confocal laser scanning microscopyTo determine the cellular uptake patterns of EGCG in nHDFs upon treatment with low and high doses of EGCG, the cells were treated for 24 h with 100 or 400 µmol/

49、L FITC-conjugated EGCG (FITC-EGCG) as described previously20. After FITCEGCG treatment, the cells were washed thoroughly with PBS, fixed with 3.5% paraformaldehyde (Sigma-Aldrich Co) in 0.1 mol/L phosphate buffer (pH 7) for 5 min at room temperature and immediately observed under a confocal laser sc

50、anning microscope (LSM 510, Carl Zeiss Advanced Imaging Microscopy, Jena, Germany). Cell nuclei were counterstained with 5 µmol/L PI immediately before 3 to 5 min of observation.Statistical analysesAll variables were tested in three independent cultures for each experiment, and each experiment

51、was repeated twice (n=6). The results are reported as the mean±standard deviation (SD) compared with the non-treated controls. A oneway analysis of variance (ANOVA), which was followed by a Tukey HSD test for the multiple comparisons, was used to detect the dose-based differential effects of EG

52、CG on nHDFs. A P value < 0.05 was considered statistically significant.ResultsEffects of EGCG on growth, morphology(形態(tài)) and cell cycle progression(進(jìn)程) of nHDFsProliferation(增殖) was inhibited(抑制) in nHDFs in a dose-differential(劑量差異) manner in response to EGCG treatment (Figure 1A). The cells part

53、ially(部分) lost their proliferation feedback(反饋) control mechanism(機(jī)制) during EGCG treatment with lower than 200 µmol/L for 24 h, but the proliferation control was slowly recovered by the cell to cell contact and returned to a normal level after the removal of EGCG from the medium (data not show

54、n). However, upon treatment with greater than 400 µmol/L EGCG, the proliferation control was not recovered in spite of EGCG removal(去除). A dose-differential modulation(調(diào)整) of cell cycle progression of nHDFs by EGCG treatment was also found. As shown in Figure 1B, EGCG treatment triggered(引發(fā)) an

55、 appreciable(明顯的) dosedependent(劑量依賴性) increase in the Sub-G1 phase (ie, 5.4%, 56.7%, and 69.9% at 200 µmol/L, 400 µmol/L, and 800 µmol/L, respectively), which corresponds(對(duì)應(yīng)) to apoptotic(細(xì)胞凋亡) cells, and a concomitant(伴隨的) decrease in S phase cells. Interestingly, 200 µmol/L EG

56、CG resulted in a slight decrease in the population of S and G2/M phases of the cell cycle, leading to cell cycle delay at the G0/G1 phase. However, EGCG treatment at a concentration(濃度) greater than 400 µmol/L resulted in a significant increase in the Sub-G1 phase of the cell cycle with a remar

57、kable decrease in the proportion(比例) of cells in both the S and the G2/M phases. Accordingly(因此), the cells could not enter the S phase during treatment with higher concentrations(濃度) of EGCG, which might induce cell cycle arrest(阻滯) as well as apoptosis(凋亡). This dose-differential antiproliferative

58、(抗增殖的) response of EGCG in nHDFs was evident from the morphological(形態(tài)的) observations (Figure 1C). The non-treated control and the lower doses (100 and 200 µmol/L) of EGCG caused only slight alterations, if any, in the cellular morphologies(形態(tài)) of nHDFs. At the higher doses (400 and 800 µm

59、ol/L), however, the number of attached cells was markedly decreased, indicating that the EGCG treatments might result in apoptotic(細(xì)胞凋亡的) detachment(脫離) of the cells.Effects of EGCG on apoptosis of nHDFsThe dose-differential effects of EGCG on apoptosis of nHDFs were evident from a DNA ladder assay,

60、 which showed the induction(電磁感應(yīng)) of DNA fragmentation(碎片) with increasing concentrations(濃度) of EGCG treatment (Figure 2A). The Annexin V-FITC assay showed that neither apoptosis(凋亡) nor necrosis(壞死) was seen at doses lower than 200 µmol/L EGCG (Figure 2B). However, treatment of nHDFs with higher concentrations of EGCG resulted in late ap